The WoundKEY test offers advanced diagnostic insights for chronic and acute wound infections, including diabetic foot ulcers, pressure ulcers, surgical wounds, chronic leg ulcers, and osteomyelitis. By detecting bacterial and fungal pathogens, this test is particularly valuable in identifying polymicrobial infections, antibiotic-resistant organisms, and cases where traditional cultures may be inconclusive, thereby facilitating accurate diagnosis and targeted antimicrobial therapy. 

Rapid sequencing using NGS technology, powered by advanced bioinformatics, enables broad microbial identification, detecting over 50,000 bacterial and fungal targets in a single sample. qPCR enables rapid detection of bacterial load and targeted pathogen identification, improving diagnostic sensitivity. The test also screens for 17 antibiotic resistance genes, supporting optimized antimicrobial therapy selection. 

Validated for wound swabs, tissue, and aspirate samples, the test includes a sample collection kit and delivers results within 3–5 days, providing clinicians with timely and precise information to guide effective wound management strategies.